IPCA LABORATORIES
Back to Cashflow Statement
|
IPCA LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,142 Cr | ₹1,321 Cr | ₹945 Cr | ₹806 Cr | ₹856 Cr |
What is the latest Cash Flow from Operating Activities ratio of IPCA LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,142 Cr |
| Mar2025 | ₹1,321 Cr |
| Mar2024 | ₹945 Cr |
| Mar2023 | ₹806 Cr |
| Mar2022 | ₹856 Cr |
How is Cash Flow from Operating Activities of IPCA LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,142 Cr | -13.57 | |
| Mar2025 | ₹1,321 Cr | 39.87 | |
| Mar2024 | ₹945 Cr | 17.23 | |
| Mar2023 | ₹806 Cr | -5.87 | |
| Mar2022 | ₹856 Cr | - | |
Compare Cash Flow from Operating Activities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,723.9 Cr | -0.3% | 0.7% | 48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -0.3% |
0.7% |
48.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses